Huron Digital Pathology, an innovative provider of whole slide scanners, and Visiopharm, the industry leader of Quantitative Digital Pathology solutions, announce today a non-exclusive distribution agreement in North America for Huron to provide their customers with Visiopharm’s ONCOtopix™ and BIOtopix™ software, along with image analysis algorithms from Visiopharm’s APPCenter.
Visiopharm’s ONCOtopix™ solutions provide efficient, high-throughput quantification of tissue based biomarkers. Biomarkers are essential to cancer diagnostics, drug development, patient stratification in conjunction with clinical trials, and for the development of companion diagnostics. All ONCOtopix™ solutions incorporate Visiopharm’s patented Virtual Double Staining, a novel method for automated, robust and verifiable tumor and stroma separation.
Furthermore, many applications in biology require the analysis of images to test scientific hypotheses and to discover novel targets for therapeutics, diagnostics and assay development. Visiopharm’s BIOtopix™ is a results driven software suite that provides an infinitely configurable toolbox for the design and implementation of image analysis algorithms. From automated tissue detection, to the alignment of serial sections, and through to the subcellular analysis of protein expression, BIOtopix™ is designed to support the scientific research of today and tomorrow.
“We are pleased to partner with Visiopharm to offer our customers a complete whole slide imaging solution that includes image analysis,” commented Patrick Myles, Executive Vice President of Business Development for Huron Digital Pathology. “We believe our customers will derive great value from the use of Visiopharm’s quantitative tools in conjunction with our TissueScope™ whole slide scanners, which will further enable the rapidly growing digital pathology market to work in an efficient, integrated digital workflow.”
Amanda Lowe, Director of Business Development for Visiopharm, stated, “We are very impressed with Huron Digital Pathology, their innovation, and their reputation within the clinical, research, and biopharmaceutical markets. This partnership will further expand the availability of Visiopharm’s solutions, and will provide Huron customers with a comprehensive total solution for digital pathology.”
Huron and Visiopharm will both be exhibiting at Pathology Informatics on May 6th and 7th in Pittsburgh, PA. Please visit with us to learn more about our products and this partnership.
About Huron Digital Pathology
We believe that innovation is the key to making digital pathology a ubiquitous reality. But for us, innovation is about more than just delivering great image quality and fast scanning speeds. It’s also about designing products that are simple to use, easy to integrate with your workflow, and have attractive price-performance characteristics.
Based in Waterloo, Ontario, Canada, Huron Digital Pathology has a 20 year history designing sophisticated imaging instrumentation. Our end-to-end digital whole slide scanning solutions for digital pathology incorporate our award-winning TissueScope™ digital slide scanners; TissueView™ image viewing, sharing and management platform; and our workflow-enhancing accessories, which include our innovative TissueSnap™ preview scanning station. Visit us at www.hurondigitalpathology.com
Visiopharm image analysis software has become the preferred Quantitative Digital Pathology solution for leading biopharmaceutical companies, contract research organizations (CRO), academic medical centers, and for hospital diagnostic pathology labs around the world. Recently Visiopharm expanded to include ONCOtopix™ Dx, a robust solution for cancer diagnostics with CE-IVD algorithms for the breast panel, integrated LIS driven workflow, and Virtual Double Staining. Our software is featured in over 800 scientific publications, and is compatible with leading slide scanner manufacturers, data management software, and a wide variety of microscopes and cameras. Our growing network of authorized distributors and integration partners support the growth of Visiopharm solutions on several continents including North America, Europe and Asia. Our headquarters is located in the Medicon Valley of Denmark, with a branch office in the Netherlands, and a North America office in Broomfield, Colorado.